Breaking News
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
November 17, 2017 - Experts identify mental exercise program that can reduce risk of dementia
November 17, 2017 - Just-in-time 3-D implants set to transform tumor surgery
November 17, 2017 - Skin patch offers hope for people with peanut allergy
November 17, 2017 - Scientists identify biomarkers that predict risk of death in Ebola patients
November 17, 2017 - Heart attack, stroke patients have improved outcomes when statins are prescribed after discharge
November 17, 2017 - Majority of people do not understand link between obesity and cancer, study shows
November 17, 2017 - Deep vein thrombosis accurately diagnosed by GPs trained in compression ultrasonography
November 17, 2017 - New Kevlar-based hydrogel recreates the magic of natural cartilage
November 17, 2017 - FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence
November 17, 2017 - Foods made with biofortified corn flour and eggs retain vitamin A after cooking
November 17, 2017 - Integrated Care Winning the Day for Healthcare Companies
November 17, 2017 - CPAP may be superior to gastric banding for severe sleep apnea
November 17, 2017 - New pain relievers reduce opiate overdose risk
November 17, 2017 - Brain astrocytes could play key role in pathogenesis of Alzheimer’s disease
November 17, 2017 - Researchers test whether LVAD surgery could reverse frailty in older adults with heart failure
November 17, 2017 - ATS debuts new video to highlight dangers of flavored tobacco
November 17, 2017 - Medicaid expansion under ACA more likely to increase smoking cessation rates among low-income adults
November 17, 2017 - FDA Approves Mepsevii (vestronidase alfa) for Mucopolysaccharidosis Type VII
November 17, 2017 - 1 in 5 Americans Still Uses Tobacco, Gov’t. Reports: MedlinePlus Health News
November 17, 2017 - People with psychotic-like experiences spend less time in healthy brain states
November 17, 2017 - Hospital Readmission Reduction Program linked to increase in death rates, study finds
November 17, 2017 - Study finds rising rates of marijuana use in states where it is legal
November 17, 2017 - Scientists unveil pathology underlying optic nerve hypoplasia in children
November 17, 2017 - Novel device designed to treat diastolic heart failure found safe and effective
November 17, 2017 - Smoking parents may underestimate kid’s exposure to secondhand smoke
November 17, 2017 - FAIMS technology holds potential to be effective screening tool for pancreatic cancer
November 17, 2017 - Applying AFM to study the viscoelastic properties of cells
November 17, 2017 - FDA Alert: Nexterone (amiodarone HCl) 150 mg/100 mL Premixed Injection: Recall
November 17, 2017 - High cognitive ability not a safeguard from conspiracies, paranormal beliefs
November 17, 2017 - Computerized speed of processing training results in decreased risk of dementia
November 17, 2017 - Sexual activity poses exceedingly small risk in causing sudden cardiac arrest
Early intervention may be crucial to successful treatment of Friedreich’s ataxia

Early intervention may be crucial to successful treatment of Friedreich’s ataxia

image_pdfDownload PDFimage_print

New research published today in Disease Models & Mechanisms indicates that early intervention should be a key target in the development of new therapeutics for Friedreich’s ataxia, as current treatments may be administered too late to target the disease effectively.

Around 1 in 50,000 people across the world are affected by Friedreich’s ataxia, an autosomal recessive inherited disease that causes progressive damage to the nervous system. Friedreich’s is the most common recessive ataxia (a lack of muscle control in voluntary movement) and results from deficient expression of the small mitochondrial protein frataxin. Mitochondria are the energy centres of the cell, relying on electron transport through a chain of enzymes that contain iron-sulphur clusters to produce the energy required for cell metabolism. Frataxin plays a vital role in this process by ensuring proper formation of the iron-sulphur clusters within the enzymes. In cells with reduced levels of frataxin, abnormal iron-sulphur cluster formation leads to decreased energy production and an accumulation of iron that induces cell-damaging reactive oxygen species (ROS). Damage from excess ROS then causes the degeneration of nervous tissue in the spinal cord. Additionally, individuals with Friedreich’s ataxia experience frequent fatigue resulting from cell metabolism defects. The usual initial symptom of the disorder is gait ataxia, a difficulty with walking that usually manifests in children between the ages of 5 and 15 years, although onset may occur in adulthood. The ataxia worsens over time and most individuals will ultimately require a wheelchair and assistance with daily tasks. Friedreich’s ataxia is commonly accompanied by a range of heart defects, and is also associated with carbohydrate intolerance and diabetes.

Identifying early deficiencies

Previous studies into Friedreich’s ataxia have investigated the direct effect of frataxin deficiency on mitochondrial enzymes that contain iron-sulphur clusters, but with a focus on nerve cell mitochondrial defects once symptoms had already been detected and the disease diagnosed. More recently, the focus of research has shifted to the deficiencies in mitochondrial biogenesis and respiratory chain complexes that occur before any symptoms are evident. Dr David Lynch, lead author on the study published in Disease Models & Mechanisms, explains that furthering knowledge of the earliest stages of Friedreich’s ataxia is essential, as their data suggest that the progressive degeneration in mitochondrial biogenesis leading to clinical disease is very slow. Lynch suggests that treatments developed to date may have failed because they didn’t target the disease at an early enough stage, and that early intervention is likely to prove crucial to successful therapy.

The advantages of slow progress

For their investigations, the team from the Children’s Hospital of Philadelphia, Weill Cornell Medical College, Queen’s University Belfast and the University of Pennsylvania used a frataxin knock-in/knockout model mouse model that has been available for a number of years, but had previously been overlooked for Friedreich’s ataxia research as the neurological phenotype is modest and has a slow onset. Lynch and the team, however, reasoned that a model that mirrored the slowly progressive nature of the disease might be more valid than the rapidly progressive mouse models more commonly used. Using this frataxin knock-in/knockout model, the researchers found significantly reduced levels of the mitochondrial biosynthesis master generator protein PGC-1α and biosynthesis pathway proteins Nrf1 and Tfam in mutant mice, even at pre-symptomatic stages of development. They also found evidence of reduced numbers of mitochondria and early mitochondrial deficiency in the cerebellar cortex. These results not only suggest early mitochondrial biogenesis deficits as a pathogenic mechanism, but also as a potential biomarker and therapeutic target in individuals with Friedreich’s ataxia.

An impact beyond Friedreich’s ataxia

Mitochondrial biogenesis deficits are associated with a number of neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, Huntington’s disease and stroke. This means that new discoveries relating to mitochondrial defects in the progression, pathology or treatment of any one of these diseases can potentially be broadly applied. Lynch says, “I think our results rationalise directed studies toward improving mitochondrial biogenesis as a long-term therapy in Friedreich’s ataxia, and that the goals of therapy must include not only correcting iron-sulphur enzymes but also other mitochondrial dysfunction. This is a target, not only in Friedreich’s ataxia, but also in Parkinson’s disease, so it is likely that collaborative drug development can move forward.”

Source:

Home

Tagged with:

About author

Related Articles